Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

291.96
BATS BZX Real-Time Price
As of 9:55am ET
 -2.72 / -0.92%
Today’s Change
281.89
Today|||52-Week Range
543.55
-22.34%
Year-to-Date

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 362.00, with a high estimate of 480.00 and a low estimate of 290.00. The median estimate represents a +23.99% increase from the last price of 291.96.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$4.58
Sales
$1.6B
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.94%
 
 
 
 
 
 
Growthannually 14.65%
 
 
 
 
 
 

Sales

Growthquarterly 3.14%
 
 
 
 
 
 
Growthannually 7.84%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.